NO126368B - - Google Patents
Download PDFInfo
- Publication number
- NO126368B NO126368B NO04900/68A NO490068A NO126368B NO 126368 B NO126368 B NO 126368B NO 04900/68 A NO04900/68 A NO 04900/68A NO 490068 A NO490068 A NO 490068A NO 126368 B NO126368 B NO 126368B
- Authority
- NO
- Norway
- Prior art keywords
- gave
- sulfate
- ethanol
- found
- aminoethyl
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 35
- 150000003839 salts Chemical class 0.000 claims description 9
- -1 alkali metal salt Chemical class 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001912 cyanamides Chemical class 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- UCQFSGCWHRTMGG-UHFFFAOYSA-N pyrazole-1-carboximidamide Chemical compound NC(=N)N1C=CC=N1 UCQFSGCWHRTMGG-UHFFFAOYSA-N 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims 2
- KTDKAQFODMVOLP-UHFFFAOYSA-N 2-pyrrolidin-1-ylguanidine Chemical class NC(=N)NN1CCCC1 KTDKAQFODMVOLP-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 44
- 229910052757 nitrogen Inorganic materials 0.000 description 34
- 229910052799 carbon Inorganic materials 0.000 description 32
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 25
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 229910052717 sulfur Inorganic materials 0.000 description 16
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 238000010626 work up procedure Methods 0.000 description 10
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 9
- BZZXQZOBAUXLHZ-UHFFFAOYSA-N (c-methylsulfanylcarbonimidoyl)azanium;sulfate Chemical compound CSC(N)=N.CSC(N)=N.OS(O)(=O)=O BZZXQZOBAUXLHZ-UHFFFAOYSA-N 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 238000005984 hydrogenation reaction Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- KDKYADYSIPSCCQ-UHFFFAOYSA-N but-1-yne Chemical compound CCC#C KDKYADYSIPSCCQ-UHFFFAOYSA-N 0.000 description 4
- FWFGVMYFCODZRD-UHFFFAOYSA-N oxidanium;hydrogen sulfate Chemical compound O.OS(O)(=O)=O FWFGVMYFCODZRD-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- ACGDKVXYNVEAGU-UHFFFAOYSA-N guanethidine Chemical compound NC(N)=NCCN1CCCCCCC1 ACGDKVXYNVEAGU-UHFFFAOYSA-N 0.000 description 3
- 229960003602 guanethidine Drugs 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 3
- ZWCHLOKPLFVXNK-UHFFFAOYSA-N 2-chloro-3-methylhex-5-yn-3-ol Chemical compound CC(Cl)C(C)(O)CC#C ZWCHLOKPLFVXNK-UHFFFAOYSA-N 0.000 description 2
- CXZJOMXTSWZMBZ-UHFFFAOYSA-N 2-tert-butyl-2-prop-2-ynyloxirane Chemical compound C#CCC1(C(C)(C)C)CO1 CXZJOMXTSWZMBZ-UHFFFAOYSA-N 0.000 description 2
- UOSRYHYUPWRJEK-UHFFFAOYSA-N 3-(chloromethyl)-2,2-dimethylhex-5-yn-3-ol Chemical compound CC(C)(C)C(O)(CCl)CC#C UOSRYHYUPWRJEK-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZQZXWCZCICKWEQ-UHFFFAOYSA-N 1-chloro-2-methylbutan-2-ol Chemical compound CCC(C)(O)CCl ZQZXWCZCICKWEQ-UHFFFAOYSA-N 0.000 description 1
- WMZWJUYJXQLURX-UHFFFAOYSA-N 1-chloro-2-methylhex-3-yn-2-ol Chemical compound CCC#CC(C)(O)CCl WMZWJUYJXQLURX-UHFFFAOYSA-N 0.000 description 1
- XEBHIUPTXHNYOD-UHFFFAOYSA-N 1-chloro-2-methylpent-4-yn-2-ol Chemical compound ClCC(O)(C)CC#C XEBHIUPTXHNYOD-UHFFFAOYSA-N 0.000 description 1
- ISNDLTAVWAJSGJ-UHFFFAOYSA-N 2-(2,3-dimethylpyrrolidin-1-yl)ethanamine Chemical compound CC1CCN(CCN)C1C ISNDLTAVWAJSGJ-UHFFFAOYSA-N 0.000 description 1
- GAZRNXIMWKZADY-UHFFFAOYSA-N 3,5-dimethylpyrazole-1-carboximidamide Chemical compound CC=1C=C(C)N(C(N)=N)N=1 GAZRNXIMWKZADY-UHFFFAOYSA-N 0.000 description 1
- ZBPJPJNOUSGZJN-UHFFFAOYSA-N 3-(chloromethyl)hex-5-yn-3-ol Chemical compound CCC(O)(CCl)CC#C ZBPJPJNOUSGZJN-UHFFFAOYSA-N 0.000 description 1
- OIMRLHCSLQUXLL-UHFFFAOYSA-N 3-chlorobutan-2-one Chemical compound CC(Cl)C(C)=O OIMRLHCSLQUXLL-UHFFFAOYSA-N 0.000 description 1
- CDJHACPKKUHUSX-UHFFFAOYSA-N 4-chloro-3-methylpent-1-yn-3-ol Chemical compound ClC(C(C#C)(O)C)C CDJHACPKKUHUSX-UHFFFAOYSA-N 0.000 description 1
- NJYOENYANQQIAS-UHFFFAOYSA-N ClC(C#CCCC)(C)O Chemical compound ClC(C#CCCC)(C)O NJYOENYANQQIAS-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- QSCPQKVWSNUJLJ-UHFFFAOYSA-N [amino(methoxy)methylidene]azanium;sulfate Chemical compound COC(N)=N.COC(N)=N.OS(O)(=O)=O QSCPQKVWSNUJLJ-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- BCUPGIHTCQJCSI-UHFFFAOYSA-N chloromethanol Chemical compound OCCl BCUPGIHTCQJCSI-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 238000001030 gas--liquid chromatography Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- YLERVAXAQFOFRI-UHFFFAOYSA-M magnesium;propa-1,2-diene;bromide Chemical compound [Mg+2].[Br-].[CH2-]C#C YLERVAXAQFOFRI-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 150000003235 pyrrolidines Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- MBEGFNBBAVRKLK-UHFFFAOYSA-N sodium;iminomethylideneazanide Chemical compound [Na+].[NH-]C#N MBEGFNBBAVRKLK-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Forbindelsene som fremstilles ifølge oppfinnelsen kan foreligge som cis- og trans-isomerer og fremstillingen av disse former kommer også innenfor oppfinnelsens ramme. Da forbindelsene også inneholder asymmetriske karbonatomer, kan de foreligge i optisk aktive former, og disse former kommer også innenfor ram-men av oppfinnelsen. The compounds produced according to the invention can exist as cis- and trans-isomers and the production of these forms also falls within the scope of the invention. As the compounds also contain asymmetric carbon atoms, they can exist in optically active forms, and these forms also come within the scope of the invention.
Uttrykket "lavere alkyl" skal her bety alkylgrupper som The term "lower alkyl" shall here mean alkyl groups which
inneholder 1 til 6 karbonatomer. contains 1 to 6 carbon atoms.
Fremgangsmåten for fremstilling av forbindelsene av formelen (I) går ut på å la et pyrrolidinalkylamin av formelen (II): The method for preparing the compounds of the formula (I) involves adding a pyrrolidine alkylamine of the formula (II):
hvor R, R^ og har samme betydning som foran nevnt, eller et salt herav, omsettes med et S-alkylisotiourinstoff, et O-alkylisourin-stoff eller et syreaddisjonssalt herav, cyanamid eller et substituert cyanamid eller et alkalimetallsalt herav, et salt av 1-guanylpyrazol eller et alkylert guanylpyrazol, som guanylerende middel. where R, R^ and have the same meaning as mentioned above, or a salt thereof, is reacted with an S-alkylisothiourea substance, an O-alkylisothiourea substance or an acid addition salt thereof, cyanamide or a substituted cyanamide or an alkali metal salt thereof, a salt of 1 -guanylpyrazole or an alkylated guanylpyrazole, as guanylating agent.
Fortrinnsvis er det guanylerende middel et S-alkyliso-tiourinstof f eller et syreaddisjonssalt herav, og dette opphetes med aminet eller saltet herav i et inert oppløsningsmiddel for å gi forbindelsen av formelen (I). Preferably, the guanylating agent is an S-alkylisothiourea or an acid addition salt thereof, and this is heated with the amine or salt thereof in an inert solvent to give the compound of formula (I).
Det skal bemerkes at i det britiske patent 933 686 er beskrevet en fremgangsmåte som kan sies å være analog med fremgangsmåten i henhold til foreliggende oppfinnelse, og videre at også forbindelsene som fremstilles i henhold til foreliggende fremgangsmåte har en noe lignende struktur som forbindelsene i henhold til nevnte patent. Imidlertid skal bemerkes at forbindelsene som fremstilles i henhold til det britiske patent omfatter et /3 ,/3-disubstituert pyrrolidin og slike forbindelser er ganske vanskelig å fremstille, mens forbindelsene i henhold til fremgangsmåten ifølge oppfinnelsen ikke omfatter noen slike ter-tiære karbonatomer og de er derfor meget lettere å fremstille. It should be noted that in British patent 933 686 a method is described which can be said to be analogous to the method according to the present invention, and further that the compounds produced according to the present method also have a somewhat similar structure to the compounds according to said patent. However, it should be noted that the compounds produced according to the British patent comprise a /3,/3-disubstituted pyrrolidine and such compounds are quite difficult to produce, while the compounds according to the method according to the invention do not comprise any such tertiary carbon atoms and the is therefore much easier to produce.
Utgangspyrrolidinalkylaminene kan fremstilles ved kata-lytisk hydrogenering i oppløsning av et tilsvarende pyrrol av formelen (III): The starting pyrrolidine alkylamines can be prepared by catalytic hydrogenation in solution of a corresponding pyrrole of the formula (III):
f.eks. ved å anvende en rhodium/aluminiumoksyd-katalysator eller 5 eller 10% Pd/c-katalysator. Når R eller R^er noe annet enn et hydrogenatom, kan det ved denne reaksjon dannes blandinger av cis-trans-isomerer. e.g. by using a rhodium/alumina catalyst or 5 or 10% Pd/c catalyst. When R or R^ is something other than a hydrogen atom, this reaction can form mixtures of cis-trans isomers.
Flere fremgangsmåter kan anvendes for å fremstille pyrrol-alkylaminene av formelen (III) , og særlig: Several methods can be used to prepare the pyrrole-alkylamines of the formula (III), and in particular:
(1) reaksjon av et acetylenisk klorkarbinol (1) reaction of an acetylenic chlorocarbinol
C1CHR . CR2(0H) . CSC^ eller ClCHR . CR2 (0H) . CH2.C<=>CH C1CHR. CR2(0H) . CSC^ or ClCHR . CR2 (0H) . CH2.C<=>CH
med et amin NH2.(CH2)n. NH2. with an amine NH2.(CH2)n. NH2.
(2) Reaksjon av et acetylenisk epoksyd av formelen: (2) Reaction of an acetylenic epoxide of the formula:
med et amin NH2. (CH2)n. NH2. with an amine NH2. (CH2)n. NH2.
(3) Ved å omdanne et pyrrolalkanol av formelen: (3) By converting a pyrrole alkanol of the formula:
til et reaktivt derivat av formelen: to a reactive derivative of the formula:
hvor X er et halogenatom eller resten av en sulfonsyre, særlig toluen-p-sulfonsyre, og denne forbindelse bringes til å reagere med et amin R^N<I>^. where X is a halogen atom or the residue of a sulphonic acid, especially toluene-p-sulphonic acid, and this compound is reacted with an amine R^N<I>^.
Pyrrolidinalkylaminene av formel (II) er også nye forbindelser likesom også et antall av de andre mellomprodukter som her er beskrevet. The pyrrolidine alkylamines of formula (II) are also new compounds, as are a number of the other intermediates described here.
Følgende eksempler skal tjene til å klargjøre oppfinnelsen: The following examples shall serve to clarify the invention:
Eksempel 1 Example 1
4-klormetylpent-l-yn-4-ol (57 g) , vannfritt etylendiamin (150 g, 166 ml) og etanol (150 ml) ble opphetet under tilbakeløp i 17 timer. Oppløsningsmidlet og overskudd av etylendiamin ble fjernet i vakuum og det ble tilsatt 40% vandig natriumhydroksyd (50 ml). Etter fjernelse av vann fra blandingen ved azeotropisk destillasjon med benzen, og fjernelse av oppløsningsmidlet fikk man en olje som ble destillert for å gi l-/3-(aminoetyl) -2,4-di-metylpyrrol (26,9 g, 45%), kp. 72°C ved 0,9 mm, n<*7>,<5>= 1,51,40. 4-Chloromethylpent-1-yn-4-ol (57 g), anhydrous ethylenediamine (150 g, 166 ml) and ethanol (150 ml) were heated under reflux for 17 hours. The solvent and excess ethylenediamine were removed in vacuo and 40% aqueous sodium hydroxide (50 ml) was added. After removal of water from the mixture by azeotropic distillation with benzene, and removal of the solvent, an oil was obtained which was distilled to give 1-(3-(aminoethyl)-2,4-dimethylpyrrole (26.9 g, 45% ), cf. 72°C at 0.9 mm, n<*7>,<5>= 1.51.40.
Dette pyrrol (13,96 g) ble hydrogenert ved romtemperatur og 35 kg/cm 2 trykk i etanol (250 ml) og 5N saltsyre (45 ml) i nær-vær av 5% rhodium/aluminiumoksyd (5 ,0 g) som. katalysator. Etter 60 timer ble katalysatoren filtrert fra og oppløsningsmidlet fjernet i vakuum.Residuet ble oppløst i vann, det ble gjort basisk med fortynnet natriumhydroksydoppløsning, og oppløsningen ble kon-tinuerlig ekstrahert med eter for å gi en olje som ved destillasjon ga l-(/3-aminoetyl)-2,4-dimetylpyrrolidin (6,98 g, 48%) kp. 71°C ved 14 mm, n<*7>= 1,4578. This pyrrole (13.96 g) was hydrogenated at room temperature and 35 kg/cm 2 pressure in ethanol (250 ml) and 5N hydrochloric acid (45 ml) in the presence of 5% rhodium/alumina (5.0 g) as. catalyst. After 60 hours, the catalyst was filtered off and the solvent removed in vacuo. The residue was dissolved in water, basified with dilute sodium hydroxide solution, and the solution was continuously extracted with ether to give an oil which on distillation gave 1-(/3 -aminoethyl)-2,4-dimethylpyrrolidine (6.98 g, 48%) b.p. 71°C at 14 mm, n<*7>= 1.4578.
[Alternativt kan hydrogeneringen utføres under anvendelse av iseddik eller vandig eddiksyre som oppløsningsmiddel istedenfor etanol - 5N saltsyre. Likeledes kan katalysatoren endres fra 5% rhodium/aluminiumoksyd til 5% palladium på benkull eller 10% palladium på benkull. Utbyttene ved hydrogeneringen varierer fra 40-60%.] [Alternatively, the hydrogenation can be carried out using glacial acetic acid or aqueous acetic acid as solvent instead of ethanol - 5N hydrochloric acid. Likewise, the catalyst can be changed from 5% rhodium/alumina to 5% palladium on bone charcoal or 10% palladium on bone charcoal. The yields in the hydrogenation vary from 40-60%.]
Pyrrolidinet (6,59 g) med S-metylisotiouroniumsulfat (6,45 g) i etanol (50 ml) og vann (30 ml) ble behandlet under til-bakeløp i 3 1/2 time. Etter avkjøling ble oppløsningen filtrert, nøytralisert med 5N svovelsyre (10 ml) og inndampet i vakuum for å gi en olje som ved kokning med etanol ga et farveløst, fast stoff. Omkrystallisering fra aceton/vann ga l-(/3-guanidinetyl) -2 ,4-dimetyl-pyrrolidinsulfathydrat (6,46 g, 50%), smp. 291-292°C. (spaltning). The pyrrolidine (6.59 g) with S-methylisothiouronium sulfate (6.45 g) in ethanol (50 mL) and water (30 mL) was refluxed for 3 1/2 hours. After cooling, the solution was filtered, neutralized with 5N sulfuric acid (10 mL) and evaporated in vacuo to give an oil which on boiling with ethanol gave a colorless solid. Recrystallization from acetone/water gave 1-([3-guanidineethyl)-2,4-dimethyl-pyrrolidine sulfate hydrate (6.46 g, 50%), m.p. 291-292°C. (fission).
Eksempel 2 Example 2
4-klormetylheks-l-yn-4-ol (52,2 g), vannfritt etylendiamin (122,0 g, 136 ml) og etanol (200 ml) ble opphetet under til-bakeløp i 30 timer. Opparbeidelse som beskrevet i eksempel 1 ga l-(/3-aminoetyl) -4-etyl-2-metylpyrrol (36,7 g, 68%), kp. 82-87°C/1,3-1,8 mm, nj° = 1,5087 4-Chloromethylhex-1-yn-4-ol (52.2 g), anhydrous ethylenediamine (122.0 g, 136 mL) and ethanol (200 mL) were heated under reflux for 30 h. Workup as described in Example 1 gave 1-((3-aminoethyl)-4-ethyl-2-methylpyrrole (36.7 g, 68%), b.p. 82-87°C/1.3-1.8 mm, nj° = 1.5087
Funnet : 71,0% C 10,5% H 18,3% n Found : 71.0% C 10.5% H 18.3% n
<C>19<H>16N2krever : 71,1% C 10,5% H 18,4% N. <C>19<H>16N2requires : 71.1% C 10.5% H 18.4% N.
Hydrogenering av pyrrolet (33,1 g) under de samme betin-gelser som beskrevet i eksempel 1 gav 1-(/3-aminoetyl) -4-etyl-2-metylpyrrolidin (12,2 g,.36%), kp. 88-89,5°C/15 mm, n^<6>,<5>= 1,4598,karakterisertsom di-toluen-p-sulfonatet, smp. 157-158°c. Hydrogenation of the pyrrole (33.1 g) under the same conditions as described in Example 1 gave 1-(β-aminoethyl)-4-ethyl-2-methylpyrrolidine (12.2 g, 36%), b.p. 88-89.5°C/15 mm, n^<6>,<5>= 1.4598, characterized as the di-toluene-p-sulfonate, m.p. 157-158°c.
Funnet:54,4% C 7,2% H 5,6% N 13,2% S Found: 54.4% C 7.2% H 5.6% N 13.2% S
C23H36<N>2<S>2°6krever : 55,2% C 7,2% H 5,6% N 12,8% S C23H36<N>2<S>2°6requires: 55.2% C 7.2% H 5.6% N 12.8% S
Behandling av'pyrrolidinet (6,0 g) med S-metylisotiouroniumsulfat (5,4 g) i vandig etanol under tilbakeløpsbehandling i 3 timer, etterfulgt av opparbeidelse som beskrevet i eksempel 1, Treatment of the pyrrolidine (6.0 g) with S-methylisothiouronium sulfate (5.4 g) in aqueous ethanol under reflux for 3 hours, followed by work-up as described in Example 1,
ga 1-(j3-guanidinetyl)'-4-etyl-2-metylpyrroiidinsulfat (8,0 g,70%) gave 1-(n3-guanidineethyl)'-4-ethyl-2-methylpyrroidine sulfate (8.0 g, 70%)
smp. 248-250,5°C (spaltning ex-etanol/vann.) m.p. 248-250.5°C (decomposition ex-ethanol/water.)
Funnet : 40,7% C 8,2% H 18,8% N 11,2% S Found : 40.7% C 8.2% H 18.8% N 11.2% S
C10H24N4S04krever : 40,6% C 8,1% H 18,9% N 10,8% S C10H24N4S04requires : 40.6% C 8.1% H 18.9% N 10.8% S
Eksempel 3 Example 3
3- brompropyn (71,5 g, 45 ml) ble oppløst i eter (200 ml) 3-bromopropyne (71.5 g, 45 mL) was dissolved in ether (200 mL)
og en 10 ml's porsjon av oppløsningen ble tilsatt til magnesium- and a 10 ml portion of the solution was added to magnesium
spon (14,65 g) dekket med eter (200 ml). Når reaksjonen var begynt, shavings (14.65 g) covered with ether (200 ml). Once the reaction had started,
ble blandingen avkjølt til -10°C og resten av 3-brompropynoppløs-ningen ble tilsatt dråpevis ved -10°C. l-klor-3,3-dimetylbutan- the mixture was cooled to -10°C and the remainder of the 3-bromopropyne solution was added dropwise at -10°C. l-chloro-3,3-dimethylbutane-
2-on (55,7 g) i benzen (200 ml) ble derpå tilsatt dråpevis og blandingen ble omrørt i ytterligere 4 timer ved -10°C. 5N svovelsyre. 2-one (55.7 g) in benzene (200 mL) was then added dropwise and the mixture was stirred for a further 4 hours at -10°C. 5N sulfuric acid.
(250 ml) ble derpå tilsatt, etterfulgt av vann (250 ml). Etter filtrering ble produktet ekstrahert i eter og eterandelen ble vas- (250 mL) was then added, followed by water (250 mL). After filtration, the product was extracted in ether and the ether portion was
ket med vann, mettet natriumhydrogenkarbonatoppløsning, og slutte- with water, saturated sodium bicarbonate solution, and finally
lig vann. Etter tørring over magnesiumsulfat ble eteren fjernet under redusert trykk. Omhyggelig fraksjonering av den rå olje (65,3 g) medførte utskillelse av 4-klormetyl-5,5-dimetylheks-l-yn-4-ol (4,2 g, 6%) kp. 65-68°C/3,6 mm, n£<4>,<5>= 1,4828, og 4-t-butyl-4,5-epoksypent-l-yn (7,9 g, 14%) kp. 36-38,5°C/3,5 mm, n^<7>= 1,4482. body of water. After drying over magnesium sulfate, the ether was removed under reduced pressure. Careful fractionation of the crude oil (65.3 g) led to the separation of 4-chloromethyl-5,5-dimethylhex-l-yn-4-ol (4.2 g, 6%) bp. 65-68°C/3.6 mm, n£<4>,<5>= 1.4828, and 4-t-butyl-4,5-epoxypent-1-yne (7.9 g, 14%) kp. 36-38.5°C/3.5 mm, n^<7>= 1.4482.
4- klormetyl-5,5-dimetylheks-l-yn-4-ol (3,0 g), vannfritt etylendiamin (6,2 g, 6,7 ml) og etanol (100 ml) ble opphetet under tilbakeløp i 24 timer. Opparbeidelse som beskrevet i eksempel 1 4-chloromethyl-5,5-dimethylhex-l-yn-4-ol (3.0 g), anhydrous ethylenediamine (6.2 g, 6.7 mL) and ethanol (100 mL) were heated under reflux for 24 h . Preparation as described in example 1
ga l-(Ø-aminoetyl)-4-t-butyl-2-metylpyrrol (2,2 g, 71%), kp. 60-62°C/0,05 mm, n^<7>1,5007. gave 1-(O-aminoethyl)-4-t-butyl-2-methylpyrrole (2.2 g, 71%), m.p. 60-62°C/0.05 mm, n^<7>1.5007.
Funnet : 73,1% C 11,3% H 15,1% N Found : 73.1% C 11.3% H 15.1% N
C11H20N2 krever : 7 3,3% C 11,1% H 15,6% N C11H20N2 requires : 7 3.3% C 11.1% H 15.6% N
Alternativt ble 4-t-butyl-4,5-epoksypent-l-yn (6,85 g), vannfritt etylendiamin (17475 g, 19,4 ml) og etanol (100 ml) opphetet under tilbakeløp i 24 timer. Oppløsningsmiddel og oversky-tende etylendiamin ble fjernet i vakuum<p>g vann ble fjernet ved azeotropisk behandling med benzen. Fjernelse av oppløsningsmiddel og destillering gav 1-(/3-aminoetyl) -4-t-butyl-2-metylpyrrol (6,4 g, 72%) o Alternatively, 4-t-butyl-4,5-epoxypent-1-yne (6.85 g), anhydrous ethylenediamine (17475 g, 19.4 mL) and ethanol (100 mL) were heated under reflux for 24 hours. Solvent and excess ethylenediamine were removed in vacuo and water was removed by azeotropic treatment with benzene. Removal of solvent and distillation gave 1-(/3-aminoethyl)-4-t-butyl-2-methylpyrrole (6.4 g, 72%) o
Hydrogenering av pyrrolet (7,0g) under de samme betin-gelser som beskrevet i eksempel 1, gav 1-(/3-aminoetyl) -4-t-butyl-2-metylpyrrolidin (4,3 g, 60%), kp. 105-109°C/14 mm, n^<1>= 1,4618. Hydrogenation of the pyrrole (7.0g) under the same conditions as described in Example 1 gave 1-((3-aminoethyl)-4-t-butyl-2-methylpyrrolidine (4.3g, 60%), bp . 105-109°C/14 mm, n^<1>= 1.4618.
Funnet : 14,8% N Found : 14.8% N
<C>11<H>24<N>2 krever:15,2% N <C>11<H>24<N>2 requires:15.2% N
Behandlingen av pyrrolidinet (3,3 g) med S-metylisotiouroniumsulfat (2,5 g) i vandig etanol under tilbakeløp i 3 1/2 time etterfulgt av opparbeidelse som beskrevet i eksempel 1, gav l-(/3-guanidinetyl)-4-t-butyl-2-metylpyrrolidinsulfat-hemihydrat (4,2 g, 70%), smp. 246-249°C (spaltning) ex-etanol/vann. Treatment of the pyrrolidine (3.3 g) with S-methylisothiouronium sulfate (2.5 g) in aqueous ethanol under reflux for 3 1/2 hours followed by work-up as described in Example 1 gave 1-(/3-guanidineethyl)-4 -t-butyl-2-methylpyrrolidine sulfate hemihydrate (4.2 g, 70%), m.p. 246-249°C (decomposition) ex-ethanol/water.
Funnet s 43,4% C 8,7% H 16,5% N 9,8% S<C>12<H>28N4S04ol//2H2° krever: 43,2% C 8,7% H 16,8% N 9,6% S Found s 43.4% C 8.7% H 16.5% N 9.8% S<C>12<H>28N4S04ol//2H2° requires: 43.2% C 8.7% H 16.8% N 9.6% S
Eksempel 4 Example 4
4-klor-3-metylpent-l-yn-3-ol (143,3 g) og vannfritt etylendiamin (450 g, 500 ml) ble opphetet under tilbakeløp i 6 døgn.Opparbeidelse som beskrevet i eksempel 1 gav 1-(/3-aminoetyl)-2 ,3-dimetylpyrrol (60,0 g, 43%), kp. 72°C/0,9 mm, n<*9>= 1,5162. 4-chloro-3-methylpent-l-yn-3-ol (143.3 g) and anhydrous ethylenediamine (450 g, 500 ml) were heated under reflux for 6 days. Workup as described in example 1 gave 1-(/ 3-aminoethyl)-2,3-dimethylpyrrole (60.0 g, 43%), b.p. 72°C/0.9 mm, n<*9>= 1.5162.
Funnet : 69,75% C 10,3 % H 20,5% N C8H14N2 krever : 69,6 % C 10,15% H 20,3% N Found : 69.75% C 10.3% H 20.5% N C8H14N2 requires : 69.6% C 10.15% H 20.3% N
Hydrogenering av pyrrolet (27,6 g) under de samme betin-gelser som beskrevet i eksempel 1, gav 1-(/3-aminoetyl) -2 ,3-dimetylpyrrolidin (16,0 g, 56,5%), kp. 81-83°C/18 mm, n20 = 1,4640,karakterisertsom dipicratet, smp. 320-321°C. Hydrogenation of the pyrrole (27.6 g) under the same conditions as described in Example 1 gave 1-(β-aminoethyl)-2,3-dimethylpyrrolidine (16.0 g, 56.5%), b.p. 81-83°C/18 mm, n20 = 1.4640, characterized as the dipicrate, m.p. 320-321°C.
Funnet : 40,0% C 4,1% H 18,5% N Found : 40.0% C 4.1% H 18.5% N
<C>20<H>24<N>8°14krever : 40,0% C 4,0% H 18,7% N <C>20<H>24<N>8°14requires : 40.0% C 4.0% H 18.7% N
Behandling av pyrrolidinet (8,0) med S-metylisotiouroniumsulfat (7^8 g) i vandig etanol under tilbakeløp i 5 timer, etterfulgt av opparbeidelse som beskrevet i eksempel 1, gav l-(/3-guanidinetyl)-2,3-dimetylpyrrolidinsulfat-hemihydrat (13,6 g, 86%), smp. 272-274°C (spaltning). Treatment of the pyrrolidine (8.0) with S-methylisothiouronium sulfate (7^8 g) in aqueous ethanol under reflux for 5 hours, followed by work-up as described in Example 1, gave 1-(/3-guanidineethyl)-2,3- Dimethylpyrrolidine sulfate hemihydrate (13.6 g, 86%), m.p. 272-274°C (decomposition).
Funnet : 37,35% C 7,8% H 19,6% N 11,2% S CgH22N4S04.l/2H20 krever : 37,15% C 7,9% H 19,2% N 11,0% S Found : 37.35% C 7.8% H 19.6% N 11.2% S CgH22N4S04.l/2H20 requires : 37.15% C 7.9% H 19.2% N 11.0% S
1-(/3-aminoetyl)-2 , 3-dimetylpyrrolidin fremstilt som beskrevet, erholdes som en blanding av cis og. trans-isomerer i det respektive forhold 65:35. Disse isomerer kan adskilles ved gass-væske-kromatografi under anvendelse av en kolonne av 20% silikon- 1-(/3-aminoethyl)-2,3-dimethylpyrrolidine prepared as described is obtained as a mixture of cis and. trans isomers in the respective ratio 65:35. These isomers can be separated by gas-liquid chromatography using a column of 20% silicone
olje DC 550 på "Celite" og nitrogen som bæregass. oil DC 550 on "Celite" and nitrogen as carrier gas.
Behandling av hver av de rene isomerer for seg med S-metylisotiouroniumsulfat på vanlig måte, etterfulgt av opparbei- Treatment of each of the pure isomers separately with S-methylisothiouronium sulfate in the usual way, followed by working up
delse som beskrevet i eksempel 1, ga cis-2,3-dimetyl-l-(/3-guani-dinetyl)-pyrrolidinsulfat, smp. 292-295°C (spaltning). divide as described in Example 1, gave cis-2,3-dimethyl-1-(β-guanidineethyl)-pyrrolidine sulfate, m.p. 292-295°C (decomposition).
Funnet : 38,6% C 8,0% H 20,0%N 11,4% S<C>9<H>22N4S04krever : 38,3% C 7,8% H 19,9% N 11,35% S Found : 38.6% C 8.0% H 20.0%N 11.4% S<C>9<H>22N4S04 required : 38.3% C 7.8% H 19.9% N 11.35% S
resp. trans-2 , 3-dimetyl-l-(/3-guanidinetyl) -pyrrol i din sul f at-hemi-hydrat, smp„ 294-295°C (spaltning). respectively trans-2,3-dimethyl-1-(/3-guanidineethyl)-pyrrole in din sulfate hemi-hydrate, m.p. 294-295°C (decomposition).
Funnet : 37,4% C 7,8% H 18,7% N 11,0% S C9<H>22N4S04.1/2H20 krever : 37,15%C 7,9% H 19,2% N 11,0% S Found : 37.4% C 7.8% H 18.7% N 11.0% S C9<H>22N4S04.1/2H20 requires : 37.15%C 7.9% H 19.2% N 11, 0% S
Eksempel 5 Example 5
3-klorbutan-2-on (210 g) i benzen (500 ml) ble tilsatt dråpevis til en omrøirt oppløsning av propargylmagnesiumbromid (fremstilt fra 3-brompropyn (357 g, 225 ml) og magnesiumspon (72 3-Chlorobutan-2-one (210 g) in benzene (500 mL) was added dropwise to a stirred solution of propargyl magnesium bromide (prepared from 3-bromopropyne (357 g, 225 mL) and magnesium shavings (72
g) som beskrevet i eksempel 3) i eter ved -10°C. Opparbeidelse som beskrevet i eksempel 3 ga 5-klor-4-metylheks-l-yn-4-ol g) as described in example 3) in ether at -10°C. Workup as described in example 3 gave 5-chloro-4-methylhex-1-yn-4-ol
(230,9 g," 80%) , kp. 35-40°C/0,7-l ,0 mm, n^<9>= 1,4702. (230.9 g," 80%) , b.p. 35-40°C/0.7-l .0 mm, n^<9>= 1.4702.
Funnet : 23,5% Cl Found : 23.5% Cl
C7HllCl° krever : 24,2% Cl C7HllCl° requires: 24.2% Cl
5-klor-4-metylheks-l-yn-4-ol (146,5 g) og etylendiamin 5-chloro-4-methylhex-l-yn-4-ol (146.5 g) and ethylenediamine
(360 g, 400 ml) ble opphetet under tilbakeløp i 3 dager. Opparbeidelse som beskrevet i eksempel 1 ga 1-(/3-aminoetyl) -2 ,3 ,5-trime-tylpyrrol (115,1 g, 76%) kp. 60-65°c/0,01 mm, n£<1>,<5>= 1,5171. (360 g, 400 mL) was heated under reflux for 3 days. Workup as described in Example 1 gave 1-((3-aminoethyl)-2,3,5-trimethylpyrrole (115.1 g, 76%) bp. 60-65°c/0.01mm, n£<1>,<5>= 1.5171.
Funnet : 70,3% C 10,6% H 18,1% N Found : 70.3% C 10.6% H 18.1% N
•<C>9<H>16N2krever : 71,1% C 10,5% H 18,4% N •<C>9<H>16N2requires: 71.1% C 10.5% H 18.4% N
Hydrogenering av pyrrolet (20 g) under de samme betin- Hydrogenation of the pyrrole (20 g) under the same conditions
gelser som beskrevet i eksempel 1, gav 1-(j3-aminoetyl-2 ,3 ,5-tri-metylpyrrolidin (15,6 g, 77%), kp. 78,5-80°C/ll mm, n^° = 1,4995,karakterisertsom dipicratet, smp. 227-228°C. gels as described in Example 1 gave 1-(3-aminoethyl-2,3,5-trimethylpyrrolidine (15.6 g, 77%), b.p. 78.5-80°C/11 mm, n^° = 1.4995, characterized as the dipicrate, mp 227-228°C.
Funnet : 41,0% C 4,3% H 18,4% N Found : 41.0% C 4.3% H 18.4% N
C21H26<N>8°14krever : 41,05%C 4,2% H 18,25% N C21H26<N>8°14requires : 41.05%C 4.2% H 18.25% N
Behandling av pyrrolidinet (7,1 g) med S-metylisotiouroniumsulfat (6,3 g) i vandig etanol under tilbakeløp i 4 timer, etterfulgt av opparbeidelse som beskrevet i eksempel 1, ga l-(/3-guanidinetyl) - >2 ,3,5,-trimetylpyrrolidinsulfat (9,7 g, 72%), smp. 275-278°C(spaltning') ex-etanol/vann. Treatment of the pyrrolidine (7.1 g) with S-methylisothiouronium sulfate (6.3 g) in aqueous ethanol under reflux for 4 h, followed by work-up as described in Example 1, gave l-(/3-guanidineethyl)- >2 , 3,5,-trimethylpyrrolidine sulfate (9.7 g, 72%), m.p. 275-278°C (decomposition') ex-ethanol/water.
Funnet : 40,3% C 8,2% H 18,7% N 10,9% S C10<H>24N4S04krever:40'6% c 8'1^ H 18/9% N 10,8% S Found : 40.3% C 8.2% H 18.7% N 10.9% S C10<H>24N4S04requires:40'6% c 8'1^ H 18/9% N 10.8% S
Eksempel 6 Example 6
Etylmagnesiumbromid (fremstilt fra etylbromid [164,0 g, 113 ml] og magnesiumspon [36,0 g] i eter) ble tilsatt i løpet av 1 time til eter (700 ml) mettet med 1-butyn. Under tilsetningen var den indre temperatur under 10°C og en stadig strøm av 1-butyn ble boblet inn i reaksjonsblandingen. Blandingen ble derpå avkjølt til 5°C, og kloraceton (93 g) ble tilsatt dråpevis. Etter omrøring natten over ved romtemperatur ble mettet ammoniumkloridoppløsning Ethyl magnesium bromide (prepared from ethyl bromide [164.0 g, 113 mL] and magnesium shavings [36.0 g] in ether) was added over 1 hour to ether (700 mL) saturated with 1-butyne. During the addition, the internal temperature was below 10°C and a steady stream of 1-butyne was bubbled into the reaction mixture. The mixture was then cooled to 5°C and chloroacetone (93 g) was added dropwise. After stirring overnight at room temperature, ammonium chloride solution was saturated
(250 ml) forsiktig tilsatt, og det resulterende anorganiske bunn-fall ble frafiltrert og vasket med eter. Filtratet ble vasket med vann, tørret over magnesiumsulfat og inndampet i vakuum, for å gi en olje (136 g). Omhyggelig fraksjonering gav 5-klor-metylheks-3-yn-5-ol (57,5 g, 39%), kp. 81°C/11 mm, n^<1>= 1,4710. (250 mL) was carefully added, and the resulting inorganic precipitate was filtered off and washed with ether. The filtrate was washed with water, dried over magnesium sulfate and evaporated in vacuo to give an oil (136 g). Careful fractionation gave 5-chloro-methylhex-3-yn-5-ol (57.5 g, 39%), b.p. 81°C/11 mm, n^<1>= 1.4710.
Funnet : 57,2% C 7,6% H ,24,5% Cl Found: 57.2% C, 7.6% H, 24.5% Cl
CyH^ClO krever : 57,3% C 7,5% H 24,2%Cl 2-klormetyl-butan-2-ol (24,0 g, 20%) ble også isolert på grunn av reaksjon mellom uendret etylmagnesiumbromid og kloraceton. CyH^ClO requires : 57.3% C 7.5% H 24.2% Cl 2-Chloromethyl-butan-2-ol (24.0 g, 20%) was also isolated due to reaction between unchanged ethylmagnesium bromide and chloroacetone .
5-klormetylheks-3-yn-5^ol (48,8 g), vannfritt etylendiamin (108,0 g, 120,0 ml) og etanol (150 ml) ble opphetet under til-bakeløp i 24 timer. Opparbeidelse som beskrevet i eksempel 1 gav 1-(/3-aminoetyl) -2-etyl-4-me tyl pyrrol (36,8 g, 73%), kp. 79-80°C/ 0,12 mm, n^<1>1,5085. 5-Chloromethylhex-3-yn-5-ol (48.8 g), anhydrous ethylenediamine (108.0 g, 120.0 mL) and ethanol (150 mL) were heated under reflux for 24 hours. Workup as described in Example 1 gave 1-(/3-aminoethyl)-2-ethyl-4-methylpyrrole (36.8 g, 73%), b.p. 79-80°C/ 0.12 mm, n^<1>1.5085.
Funnet : 70,4% C 10,8% H 18,0% N C9H16N2 kre,/er571 c 10,5% H 18,4% N Found : 70.4% C 10.8% H 18.0% N C9H16N2 kre,/er571 c 10.5% H 18.4% N
Hydrogenering av pyrrolet (20 g) under de samme betingel-ser som beskrevet i eksempel 1, gav 1-(/3-aminoetyl) -2-etyl-4-metyl-pyrrolidin (18,1 g, 88%), kp. 82°c/12 mm, n^<1>= 1,4610,karakterisertsom dipicratet, smp. 180-181°C. Hydrogenation of the pyrrole (20 g) under the same conditions as described in Example 1 gave 1-(β-aminoethyl)-2-ethyl-4-methyl-pyrrolidine (18.1 g, 88%), b.p. 82°c/12 mm, n^<1>= 1.4610, characterized as the dipicrate, m.p. 180-181°C.
Funnet : 41,3 %C 4,3% H 18,1 %N Found : 41.3%C 4.3%H 18.1%N
<C>21<H>26<N>8°14krever : 41/05% C 4,2% H 18,25% N <C>21<H>26<N>8°14requires : 41/05% C 4.2% H 18.25% N
Behandling av pyrrolidin (7,6 g) med S-metylisotiouroniumsulfat (6,95 g) i vandig etanol under tilbakeløp i 4 1/2 time, etterfulgt av opparbeidelse som beskrevet i eksempel 1, gav 1-0-guanidinetyl)-2-etyl-4-metylpyrrolidinsulfat (10,6 g, 71%), smp. 272-274°c (spaltning) ex-etanol/vann. Treatment of pyrrolidine (7.6 g) with S-methylisothiouronium sulfate (6.95 g) in aqueous ethanol under reflux for 4 1/2 hours, followed by work-up as described in Example 1, gave 1-O-guanidineethyl)-2- ethyl 4-methylpyrrolidine sulfate (10.6 g, 71%), m.p. 272-274°c (decomposition) ex-ethanol/water.
Funnet : 40,05% C 8,2% H 18,6% N 11,4% S C10H24N4S04krever : 40,6% C 8,1% H 18,9% N 10,8% S Found : 40.05% C 8.2% H 18.6% N 11.4% S C10H24N4S04 required : 40.6% C 8.1% H 18.9% N 10.8% S
Eksempel 7 Example 7
En blanding av l-guanyl-3,5-dimetylpyrazolnitrat og 1-(/3-aminoetyl) -2 ,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1) ble opphetet i 2 1/2 time under omrøring. Overskudd av amin ble fjernet i vakuum, og residuet ble oppløst i vann og om- A mixture of 1-guanyl-3,5-dimethylpyrazole nitrate and 1-(/3-aminoethyl)-2,4-dimethylpyrrolidine (prepared as described in Example 1) was heated for 2 1/2 hours with stirring. Excess amine was removed in vacuo, and the residue was dissolved in water and re-
dannet til det ønskede l-(/3-guanidinetyl) -2 ,4-dimetylpyrrolidin-sulfathydrat ved behandling med en sterk anion(sulfat-)utvekslings-harpiks. Den resulterende oppløsning ble inndampet under redu- formed to the desired 1-(/3-guanidineethyl)-2,4-dimethylpyrrolidine sulfate hydrate by treatment with a strong anion (sulfate) exchange resin. The resulting solution was evaporated under redu-
sert trykk og residuet ble omkrystallisert fra vandig etanol. pressure and the residue was recrystallized from aqueous ethanol.
Produktet var identisk med det som ble oppnådd i henhold til ek- The product was identical to that obtained according to ec-
sempel 1. simple 1.
Eksempel 8 Example 8
En oppløsning av l-(/3-aminoetanol) -2 ,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1) i etanol ble nøytralisert med 5N svovelsyre, det ble tilsatt cyanamid og blandingen ble opphetet under tilbakeløp i 6 timer. Fjernelse av oppløsningsmiddel og omkrystallisering av residuet fra vandig etanol gav l-(/3-guani-dinetyl)-2,4-dimetylpyrrolidin-sulfathydrat, identisk med den forbindelse som ble erholdt i henhold til eksempel 1. A solution of 1-(/3-aminoethanol)-2,4-dimethylpyrrolidine (prepared as described in Example 1) in ethanol was neutralized with 5N sulfuric acid, cyanamide was added and the mixture was heated under reflux for 6 hours. Removal of solvent and recrystallization of the residue from aqueous ethanol afforded 1-(/3-guanidineethyl)-2,4-dimethylpyrrolidine sulfate hydrate, identical to the compound obtained according to Example 1.
Eksempel 9, Example 9,
En oppløsning av l-(0-aminoetyl)-2,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1.) i vann ble nøytralisert med A solution of 1-(0-aminoethyl)-2,4-dimethylpyrrolidine (prepared as described in Example 1.) in water was neutralized with
.5N svovelsyre, det ble tilsatt en ekvivalent mengde av mononatrium-cyanamid, og blandingen ble opphetet under tilbakeløp i 8 timer.Blandingen ble derpå behandlet med en ekvivalent mengde av 5N svo-vélsyre og inndampet i vakuum. Omkrystallisering av residuet fra etanol/vann gav det ønskede 1-(/3-guanidinmetyl) -2 ,4-dimetylpyrrolidin'-sul f athydrat . Produktet var identisk med den forbindelse som .5N sulfuric acid, an equivalent amount of monosodium cyanamide was added, and the mixture was heated under reflux for 8 hours. The mixture was then treated with an equivalent amount of 5N sulfuric acid and evaporated in vacuo. Recrystallization of the residue from ethanol/water gave the desired 1-((3-guanidinemethyl)-2,4-dimethylpyrrolidine'-sulphate hydrate). The product was identical to the compound which
man erholdt i eksempel 1. obtained in example 1.
Eksempel 22 Example 22
1-(/3-aminoetyl)-2 ,4-dimetylpyrrolidin (fremstilt som beskrevet i eksempel 1) og O-metylisouroniumsulfat ble oppløst i vandig etanol og opphetet under tilbakeløp i 4 timer. Etter nøytrali-sering med 5N svovelsyre, ble blandingen inndampet i vakuum og krys-tallisering av residuet fra etanol/vann gav det ønskede l-(/3-guani-dinetyl)-2,4-dimetylpyrrolidin-sulfathydrat. Produktet var identisk med den forbindelse som man erholdt i eksempel 1. 1-(/3-Aminoethyl)-2,4-dimethylpyrrolidine (prepared as described in Example 1) and O-methylisouronium sulfate were dissolved in aqueous ethanol and heated under reflux for 4 hours. After neutralization with 5N sulfuric acid, the mixture was evaporated in vacuo and crystallization of the residue from ethanol/water gave the desired 1-((3-guanidineethyl)-2,4-dimethylpyrrolidine sulfate hydrate). The product was identical to the compound obtained in example 1.
I den nedenfor anførte tabell er innført aktiviteten av visse forbindelser som fremstilles i henhold til foreliggende oppfinnelse sammenlignet med den antihypertensive aktivitet av guanetidin som muligens er det beste antihypertensive middel som for tiden er tilgjengelig. Guanetidin har formelen: In the table below, the activity of certain compounds produced according to the present invention is compared with the antihypertensive activity of guanethidine, which is possibly the best antihypertensive agent currently available. Guanethidine has the formula:
som er den mest aktive forbindelse som fremstilles i henhold til norsk, patent 98 970. which is the most active compound produced according to Norwegian patent 98 970.
Forbindelsene som fremstilles i henhold til oppfinnelsen ble undersøkt subkutant og oralt med hensyn til antihypertensiv aktivitet i hypertensive rotter, og det ble bestemt de doser som medfører et 20%'s fall i blodtrykket. Aktivitetene er gjengitt i forhold til aktiviteten av guanetidin som er gitt verdien 1,00. The compounds produced according to the invention were examined subcutaneously and orally with regard to antihypertensive activity in hypertensive rats, and the doses which cause a 20% drop in blood pressure were determined. The activities are reproduced in relation to the activity of guanethidine, which is given the value 1.00.
Hver forbindelse ble undersøkt som sulfatet. Resultatene er anført for et 65:35 forhold av cis- til trans-isomerer. Each compound was examined as the sulfate. The results are given for a 65:35 ratio of cis to trans isomers.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB55708/67A GB1185080A (en) | 1967-12-07 | 1967-12-07 | Pyrrolidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO126368B true NO126368B (en) | 1973-01-29 |
Family
ID=10474656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO04900/68A NO126368B (en) | 1967-12-07 | 1968-12-06 |
Country Status (16)
| Country | Link |
|---|---|
| AT (1) | AT301569B (en) |
| BE (1) | BE725104A (en) |
| BR (1) | BR6804654D0 (en) |
| CH (1) | CH534679A (en) |
| DE (1) | DE1811832A1 (en) |
| DK (1) | DK126781B (en) |
| ES (1) | ES361114A1 (en) |
| FR (1) | FR7874M (en) |
| GB (1) | GB1185080A (en) |
| IE (1) | IE32781B1 (en) |
| IL (1) | IL31228A (en) |
| IS (1) | IS1807A7 (en) |
| NL (1) | NL6817322A (en) |
| NO (1) | NO126368B (en) |
| SE (1) | SE346785B (en) |
| ZM (1) | ZM17068A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3527791A1 (en) * | 1985-08-02 | 1987-02-12 | Cassella Ag | 2,5-DIMETHYLPYRROL DERIVATIVES, THEIR PRODUCTION AND THEIR USE |
| TW224974B (en) * | 1991-07-02 | 1994-06-11 | Hoffmann La Roche | |
| GB9803536D0 (en) * | 1998-02-19 | 1998-04-15 | Black James Foundation | Histamine H,receptor ligands |
-
1967
- 1967-12-07 GB GB55708/67A patent/GB1185080A/en not_active Expired
-
1968
- 1968-11-28 IE IE1454/68A patent/IE32781B1/en unknown
- 1968-11-29 DE DE19681811832 patent/DE1811832A1/en active Pending
- 1968-12-02 IS IS1807A patent/IS1807A7/en unknown
- 1968-12-03 NL NL6817322A patent/NL6817322A/xx unknown
- 1968-12-04 ZM ZM170/68A patent/ZM17068A1/en unknown
- 1968-12-04 AT AT1180468A patent/AT301569B/en not_active IP Right Cessation
- 1968-12-05 ES ES361114A patent/ES361114A1/en not_active Expired
- 1968-12-05 DK DK594468AA patent/DK126781B/en unknown
- 1968-12-05 IL IL31228A patent/IL31228A/en unknown
- 1968-12-06 BE BE725104D patent/BE725104A/xx unknown
- 1968-12-06 NO NO04900/68A patent/NO126368B/no unknown
- 1968-12-06 SE SE16737/68A patent/SE346785B/xx unknown
- 1968-12-06 FR FR176948A patent/FR7874M/fr not_active Expired
- 1968-12-06 BR BR204654/68A patent/BR6804654D0/en unknown
- 1968-12-09 CH CH1833468A patent/CH534679A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE725104A (en) | 1969-06-06 |
| IL31228A0 (en) | 1969-02-27 |
| BR6804654D0 (en) | 1973-02-13 |
| GB1185080A (en) | 1970-03-18 |
| ES361114A1 (en) | 1970-08-01 |
| CH534679A (en) | 1973-03-15 |
| FR7874M (en) | 1970-04-27 |
| ZM17068A1 (en) | 1969-06-17 |
| NL6817322A (en) | 1969-06-10 |
| DE1811832A1 (en) | 1969-07-03 |
| IL31228A (en) | 1972-04-27 |
| IS1807A7 (en) | 1969-01-22 |
| SE346785B (en) | 1972-07-17 |
| AT301569B (en) | 1972-09-11 |
| DK126781B (en) | 1973-08-20 |
| IE32781B1 (en) | 1973-11-28 |
| IE32781L (en) | 1969-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU793382A3 (en) | Method of preparing triphenylalkene derivatives or their salts | |
| DK158307B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 4- (PHENYLALKYL) IMIDAZOLD DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF | |
| CH648553A5 (en) | NEW 3,4-DIHYDRO-5H-2,3-BENZODIAZEPINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. | |
| DK145260B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 4-ACYLAMINO-PHENYL-ETHANOLAMINES OR ACID ADDITION SALTS | |
| CS241016B2 (en) | Method of new n-(2-(or)pyrrolidinylmethyl)-benzamides production substituted in positions 2,3,4,5,6 | |
| NO860285L (en) | PROCEDURE FOR THE PREPARATION OF IMIDAZOLD DERIVATIVES. | |
| DE68924751T2 (en) | Azacyclic compounds useful as medicines. | |
| NO313196B1 (en) | Pyrimidinylpyrazole derivative, and anti-tumor agent containing it | |
| DE1595920A1 (en) | 4- (omega-piperazinoalkyl) pyrazoles, their salts and processes for their preparation | |
| US4094987A (en) | 2-(3-m-hydroxy-phenyl-1-substituted-3-pyrrolidinyl)-ethanols | |
| NO126368B (en) | ||
| SU683623A3 (en) | Method of the preparation of purine derivatives or their salts | |
| US2617825A (en) | Process for preparation of salts of 1-amino-2-haloethanes | |
| DE69501791T2 (en) | INDOL DERIVATIVES AS 5-HT1 LIKE AGONISTS | |
| Corrigan et al. | Preparation of N-substituted 1-(p-hydroxyphenyl)-2-aminoethanols1 | |
| JPS5934709B2 (en) | Method for producing chlorinated imidazole derivatives | |
| US3903104A (en) | 1-(2-{66 {HU 2{B -Imidazolinyl)-2,2-diarylcyclopropanes and process | |
| DE3750117T2 (en) | Process for the preparation of indolinone-2 derivatives. | |
| EP0025501B1 (en) | N-aminoalkyl indole derivatives and their salts, processes for their preparation and medicaments containing these compounds | |
| EP1124805B1 (en) | Method for producing 4-[(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols | |
| Katritzky et al. | Synthesis and reactions of lithio derivatives of 1‐allenylbenzotriazole | |
| DE2409313A1 (en) | NEW PYRROLYL COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION | |
| IE52102B1 (en) | Indole and indoline derivatives | |
| US2782191A (en) | Nitrogen containing carbinols | |
| SU655307A3 (en) | Method of obtaining guanidine derivatives or salts thereof |